Amount of additional milestone payable.

No definition available.

Name:	iova_AdditionalMilestonePayable
Namespace Prefix:	iova_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

It represents the term of agreement.

+ References

No definition available.

+ Details

Name:	iova_AgreementTerm
Namespace Prefix:	iova_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The notice period for termination of collaboration arrangement before regulatory approval.

+ References

No definition available.

+ Details

Name:	iova_CollaborationArrangementTerminationNoticePeriodBeforeRegulatoryApproval
Namespace Prefix:	iova_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The notice period for termination of collaboration arrangement post regulatory approval.

+ References

No definition available.

+ Details

Name:	iova_CollaborationArrangementTerminationNoticePeriodPostRegulatoryApproval
Namespace Prefix:	iova_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The required notification period before the party may terminate the agreement.

+ References

No definition available.

+ Details

Name:	iova_NotificationPeriodToTerminateAgreement
Namespace Prefix:	iova_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of statements of work under the agreement.

+ References

No definition available.

+ Details

Name:	iova_NumberOfStatementsOfWork
Namespace Prefix:	iova_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of suites under the agreement.

+ References

No definition available.

+ Details

Name:	iova_NumberOfSuitesUnderAgreement
Namespace Prefix:	iova_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

This element represents the amount of cash outflow for the payment of upfront licensing fee.

+ References

No definition available.

+ Details

Name:	iova_PaymentsForUpfrontLicensingFee
Namespace Prefix:	iova_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 730
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=iova_StrategicAllianceAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=iova_ResearchCollaborationAndClinicalGrantAgreementsWithMoffittMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=iova_SponsoredResearchAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=iova_SecondLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=iova_FirstWuxiManufacturingAndServicesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=iova_SecondWuxiManufacturingAndServicesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iova_CooperativeResearchAndDevelopmentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iova_MoffittLicenseAgreementOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iova_MoffittLicenseAgreementTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iova_MoffittLicenseAgreementTwoAmendedAndRestatedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iova_CellectisS.aMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iova_NovartisPharmaAgLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

LICENSES AND AGREEMENTS (Details) $ in Thousands				1 Months Ended				3 Months Ended		9 Months Ended		12 Months Ended		21 Months Ended
LICENSES AND AGREEMENTS (Details) $ in Thousands	May 07, 2018 USD ($)	Apr. 17, 2017 USD ($)	Jun. 28, 2014 USD ($)	Oct. 31, 2022 item	Aug. 31, 2021 USD ($)	Nov. 30, 2016 item	Aug. 31, 2011	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Sep. 30, 2022 USD ($)
Research and development								$ 72,502	$ 65,355	$ 214,208	$ 183,423
Strategic Alliance Agreement
Research and development								100	100	100	200
Research Collaboration And Clinical Grant Agreements With Moffitt
Research and development										100
Maximum \| Strategic Alliance Agreement
Research and development arrangement, contract to perform for others, costs incurred, gross		$ 14,200
Sponsored research agreement
Research and development								300	300	500	300
Second license agreement
Research and development										100	100
First WuXi Manufacturing and Services Agreement
Agreement term						3 years
Research and development								3,400	4,500	10,600	12,700
Number Of Statements Of Work \| item						1
Number Of Suites Under The Agreement \| item						2
Second WuXi Manufacturing and Services Agreement
Agreement term				3 years
Number Of Suites Under The Agreement \| item				2
Termination notice period				120 days
Post regulatory before the termination date				15 months
Research and development \| Strategic Alliance Agreement
Research and development arrangement, contract to perform for others, costs incurred, gross										7,000
Cooperative Research and Development Agreement
Agreement term					3 years		5 years
Research and development					$ 500			500	500	1,500	1,500
Notification Period To Terminate Agreement					60 days
Moffitt License Agreement One
Agreement term			20 years
Research and development								0	0	0	0
Moffitt License Agreement One \| Research and development
Payments for upfront licensing fee			$ 100
Moffitt License Agreement Two
Payments for upfront licensing fee	$ 100
Additional milestone payable								400		400				$ 400
Moffitt License Agreement Two, Amended and Restated
Payments for upfront licensing fee												$ 200
Cellectis S.A
Research and development								100	100					$ 300
Novartis Pharma AG - License Agreement
Research and development								$ 0	$ 0	$ 0	$ 0		$ 10,000